Seven faculty members from HMS are among the 70 new appointees to the Institute of Medicine (IOM) of the National Academy of Sciences. Established in 1970, the institute is both an honorific membership organization and an advisory group that analyzes health issues and makes recommendations on national health policy.
Sign up for more Harvard Medical School news here
Appointment recognizes individuals who have demonstrated outstanding professional achievement and dedication to service. With their election, members make a commitment to volunteer a significant amount of time on IOM committees, which engage in a broad range of studies on health policy issues.
The new members from HMS are listed below.
Elliot Chaikof, Johnson and Johnson Professor of Surgery, Harvard Medical School; chairman, Roberta and Stephen R. Weiner Department of Surgery; and surgeon-in-chief, Beth Israel Deaconess Medical Center
E. Antonio Chiocca, neurosurgeon-in-chief and chairman, department of neurosurgery, and co-director, Institute for the Neurosciences, Brigham and Women’s/Faulkner Hospital; surgical director, Center for Neuro-oncology, Dana-Farber Cancer Institute; and Harvey W. Cushing Professor of Neurosurgery, Harvard Medical School
Todd Golub, investigator, Howard Hughes Medical Institute; chief scientific officer, Broad Institute of Harvard and MIT; and Charles A. Dana Investigator and HMS professor of pediatrics Dana-Farber Cancer Institute
Bradley Hyman, John B. Penney Jr. Professor of Neurology, Harvard Medical School, and Alzheimer’s Unit Director, MassGeneral Institute for Neurodegenerative Disease
Paula Johnson, professor of medicine, Harvard Medical School; professor of epidemiology, Harvard School of Public Health; executive director, Connors Center for Women’s Health and Gender Biology; and chief, division of women’s health, Brigham and Women’s Hospital
Margaret Shipp, chief, division of hematologic neoplasia and HMS professor of medicine, Dana-Farber Cancer Institute
Bruce Spiegelman, HMS Stanley J. Korsmeyer Professor of Cell Biology and Medicine, Dana-Farber Cancer Institute
